Enovis Corporation (ENOV) — Analysis Summary
Enovis Corporation (ENOV) has a market cap of $1.31B with year-over-year revenue growth of +6.7%. Net margin stands at -52.7%. The stock trades at a P/E ratio of -1.1.
Key Takeaways
- Revenue changed +6.7% year-over-year
- Net margin of -52.7%
- P/E ratio of -1.1
Compared to other companies in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector, ENOV posted revenue growth of +6.7% and trades at a P/E of -1.1.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.